X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4959) 4959
Newsletter (332) 332
Newspaper Article (47) 47
Book Chapter (17) 17
Dissertation (5) 5
Publication (4) 4
Book / eBook (1) 1
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tacrolimus (3914) 3914
humans (3529) 3529
index medicus (2450) 2450
male (2367) 2367
transplantation (2360) 2360
female (2083) 2083
adult (1659) 1659
middle aged (1577) 1577
pharmacology & pharmacy (1574) 1574
immunosuppressive agents - pharmacokinetics (1564) 1564
pharmacokinetics (1545) 1545
tacrolimus - pharmacokinetics (1481) 1481
cyclosporine (1279) 1279
immunosuppressive agents - therapeutic use (1262) 1262
tacrolimus - administration & dosage (1153) 1153
surgery (1118) 1118
immunosuppressive agents - administration & dosage (1112) 1112
tacrolimus - therapeutic use (1097) 1097
kidney transplantation (1084) 1084
kidneys (800) 800
immunology (792) 792
tacrolimus - blood (720) 720
immunosuppressive agents - blood (708) 708
aged (694) 694
recipients (689) 689
animals (687) 687
immunosuppressive agents - adverse effects (628) 628
immunosuppression (618) 618
adolescent (612) 612
analysis (601) 601
calcineurin inhibitors (594) 594
graft rejection - prevention & control (572) 572
treatment outcome (556) 556
liver (543) 543
organ transplant recipients (542) 542
research (541) 541
liver transplantation (538) 538
tacrolimus - adverse effects (528) 528
child (508) 508
drug interactions (505) 505
fk506 (482) 482
dose-response relationship, drug (473) 473
retrospective studies (471) 471
area under curve (470) 470
mycophenolic acid - analogs & derivatives (470) 470
drug therapy, combination (457) 457
transplants & implants (453) 453
genotype (446) 446
pharmacogenetics (443) 443
cytochrome p-450 cyp3a - genetics (416) 416
young adult (415) 415
immunosuppressive agents (400) 400
time factors (399) 399
sirolimus (381) 381
health aspects (379) 379
tacrolimus - pharmacology (376) 376
immunosuppressive agents - pharmacology (365) 365
cyclosporine - therapeutic use (363) 363
cyp3a5 (358) 358
toxicology (352) 352
mycophenolic acid - pharmacokinetics (349) 349
fk-506 (348) 348
metabolism (345) 345
renal-transplantation (343) 343
kidney-transplantation (341) 341
mycophenolate mofetil (341) 341
acute rejection (334) 334
rats (327) 327
cyclosporine-a (324) 324
medical research (323) 323
therapy (316) 316
pediatrics (313) 313
child, preschool (311) 311
rejection (310) 310
kidney transplantation - immunology (309) 309
prospective studies (303) 303
cyclosporine - pharmacokinetics (302) 302
medicine, experimental (302) 302
mycophenolic acid (300) 300
p-glycoprotein (300) 300
mycophenolic acid - therapeutic use (299) 299
drug monitoring (298) 298
medical laboratory technology (293) 293
clinical pharmacokinetics (291) 291
administration, oral (287) 287
risk factors (287) 287
drugs (284) 284
children (279) 279
transplantation of organs, tissues, etc (279) 279
graft rejection (277) 277
mycophenolate-mofetil (277) 277
follow-up studies (273) 273
immunotherapy (264) 264
drug administration schedule (262) 262
pharmacology (262) 262
renal transplantation (260) 260
efficacy (259) 259
medicine & public health (255) 255
pharmacodynamics (246) 246
dosage and administration (240) 240
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5284) 5284
Japanese (92) 92
French (19) 19
Chinese (15) 15
Spanish (11) 11
German (8) 8
Korean (5) 5
Polish (2) 2
Russian (2) 2
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Transplantation, ISSN 1600-6135, 05/2015, Volume 15, Issue 5, pp. 1313 - 1322
...) on the pharmacokinetics, safety, and tolerability of a single dose of cyclosporine (30 mg) or tacrolimus (2 mg) in healthy volunteers... 
infectious disease | clinical research/practice | pharmacology | calcineurin inhibitor: cyclosporine A (CsA) | pharmacokinetics/pharmacodynamics | immunosuppressant | infection and infectious agents | calcineurin inhibitor: tacrolimus | liver transplantation/hepatology | viral: hepatitis C | SURGERY | ABT-450/R-OMBITASVIR | LIVER-TRANSPLANTATION | EFFICACY | DRUG-INTERACTIONS | TRANSPORTERS | HCV | INFECTION | RIBAVIRIN | INHIBITOR | HEPATITIS-C | TRANSPLANTATION | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Area Under Curve | Humans | Middle Aged | Male | Anilides - pharmacokinetics | Carbamates - administration & dosage | Healthy Volunteers | Carbamates - pharmacokinetics | Young Adult | Uracil - administration & dosage | Cyclosporine - pharmacokinetics | Adult | Female | Tacrolimus - administration & dosage | Hepacivirus - drug effects | Drug Administration Schedule | Macrocyclic Compounds - pharmacokinetics | Tacrolimus - pharmacokinetics | Antiviral Agents - administration & dosage | Sulfonamides - pharmacokinetics | Anilides - administration & dosage | Adolescent | Cyclosporine - administration & dosage | Macrocyclic Compounds - administration & dosage | Uracil - pharmacokinetics | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Dosage and administration | Liver diseases | Drug therapy, Combination | Tacrolimus | Hepatitis C virus | Hepatitis C | Hepatitis | Medical research | Drug dosages | practice | pharmacodynamics | hepatology | clinical research | pharmacokinetics | Original | liver transplantation
Journal Article
Pharmacogenetics and Genomics, ISSN 1744-6872, 05/2013, Volume 23, Issue 5, pp. 251 - 261
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 12/2012, Volume 34, Issue 6, pp. 660 - 670
Journal Article
Transplantation Proceedings, ISSN 0041-1345, 2016, Volume 48, Issue 2, pp. 420 - 423
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 05/2018, Volume 58, Issue 5, pp. 666 - 673
.... The aim of the present study was to assess the safety and pharmacokinetic interactions between EBR and GZR and single doses of cyclosporine, tacrolimus, mycophenolate mofetil (MMF), and prednisone. This was a 4‐part, open... 
cyclosporine | drug‐drug interactions | tacrolimus | pharmacokinetics | grazoprevir | mycophenolate mofetil | prednisone | elbasvir | drug-drug interactions | EFFICACY | GRAZOPREVIR MK-5172 | SAFETY | COMBINATION THERAPY | LABEL PHASE-2 TRIAL | RIBAVIRIN | HEPATITIS-C VIRUS | GENOTYPE 1 INFECTION | PHARMACOLOGY & PHARMACY | ELBASVIR MK-8742 | TREATMENT-NAIVE PATIENTS | Quinoxalines - adverse effects | Antiviral Agents - pharmacokinetics | Area Under Curve | Humans | Immunosuppressive Agents - pharmacokinetics | Middle Aged | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Male | Imidazoles - pharmacokinetics | Benzofurans - pharmacokinetics | Young Adult | Drug Interactions | Cyclosporine - pharmacokinetics | Adult | Female | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Quinoxalines - pharmacokinetics | Prednisone - adverse effects | Quinoxalines - administration & dosage | Administration, Oral | Imidazoles - adverse effects | Mycophenolic Acid - pharmacokinetics | Tacrolimus - pharmacokinetics | Tacrolimus - adverse effects | Antiviral Agents - administration & dosage | Benzofurans - adverse effects | Mycophenolic Acid - adverse effects | Antiviral Agents - adverse effects | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Prednisone - pharmacokinetics | Immunosuppressive Agents - adverse effects | Drug Combinations | Drugs | Mycophenolic acid | Cyclosporins | Transaminase | Viruses | Prednisone | Pharmacology | Hepatitis | Tacrolimus | Mycophenolate mofetil | Hepatitis C virus | Pharmacokinetics | Hepatitis C | Drug dosages | Prednisolone
Journal Article